About Us
Dr Agarwals Eye Hospital houses world class facility with finest equipment and experienced consultants and technical team, With over 60+years of experience and having 250+centres in India, the Clinical Research Division is dedicated to pioneering innovations in eye care. We conduct ethically sound, patient-centric studies that contribute to global ophthalmic knowledge and improve treatment outcomes.
Our Clinical Research Team
Each team member brings unique expertise and a commitment to advancing eye care through research.
EC registration – 11 sites
Ongoing Clinical Studies
Chennai
TTK Road
View On Google Maps
Tambaram
View On Google Maps
Bangalore
White Field
View On Google Maps
Punjab
Chandigarh
View On Google Maps
Mohali
View On Google MapsOur current research portfolio includes:
|
Sr. No. |
Name of the project |
Indication |
Principal Investigator |
Status |
CTRI |
|
1 |
A single-centre, prospective, randomized, single-masked, controlled clinical trial to evaluate the DIMSHYP spectacle lenses visual performance and reduction of hyperopia in children |
Hyperopia |
Dr Triveni Venkat |
Ongoing |
|
|
2 |
A prospective, randomized, multi-centre, open-label study to evaluate the safety and effectiveness of Menicon Bloom Night lenses compared to an available registered brand of orthokeratology lenses, and spectacles for myopia control, and single vision spectacles in Indian children |
Myopia |
Dr. Ashvin Agarwal |
Ongoing |
|
|
3 |
A prospective, Multicenter Clinical Study Comparing The effects of two trifocal Toric Intraocular Lenses |
Cataract |
Dr. Ashvin Agarwal |
Ongoing |
|
|
4 |
A prospective, randomized clinical study of two phakic toric implantable lenses to compare outcomes in patients with moderate to high myopia and astigmatism. |
Myopia |
Dr. Preeti Naveen |
Ongoing |
|
|
5 |
To evaluate efficacy and safety of R-TPR-023 / Lucentis® in patients with neovascular (wet) age-related macular degeneration. |
w-AMD |
Dr. Manoj Khatri |
To be initiated |
|
|
6 |
A Prospective, Multi-center, Single-arm, Phase IV Study to Assess the Safety, Efficacy and Immunogenicity of Ranibizumab Solution for Injection 10 mg/mL (r-DNA Origin) |
wAMD |
Feasibility Completed |
Office Address
No.222, TTK Road, Alwarpet
Near Raj Park Hotel, Chennai - 600018.
